-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.↓USDISIN US05464T1043-
AXSOME THERAPEUTICS INCBörse Börse FrankfurtEURSymbol 19X
-
AXSOME THERAPEUTICS INCBörse Börse MünchenEURSymbol 19X
-
AXSOME THERAPEUTICS INCBörse Börse BerlinEURSymbol 19X
-
AXSOME THERAPEUTICS INCBörse Tradegate System der Deutsche Börse AG (60%)EURSymbol 19X
-
AXSOME THERAPEUTICS INCBörse Gettex System der Börse MünchenEURSymbol 19X
-
AXSOME THERAPEUTICS INCBörse Börse DüsseldorfEURSymbol 19X
-
AXSOME THERAPEUTICS INCBörse Quotrix System der Börse DüsseldorfEURSymbol 19X
-
ISIN US05464T1043 WKN: A2AA7BUSDSymbol AXSM
-
EUR
-
USD
-
ISIN US05464T1043
WKN A2AA7B
Symbol AXSM
Währung
USD
Firmenname
Axsome Therapeutics, Inc
Marktkapitalisierung
2.494.550.656 (+- 10%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
2.745.101.312 oder 2.244.000.000
Mitarbeiter
223 (+- 76%)
Die einen sagen so, die anderen so... Es gibt 2 Datenquellen:
53 oder 393 Mitarbeiter
EBITDA -41.298.216
Buchwert 3.622
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von 59,41 USD -2,60%
Portrait der Axsome Therapeutics Aktie
Das Unternehmen Axsome Therapeutics, Inc aus USA beschäftigt 223 Mitarbeiter und ist in den Bereichen Chemie & Pharma, Biotechnologie tätig.
Das Unternehmen Axsome Therapeutics, Inc ist nur in 6 ETFs enthalten und somit eine nicht sonderlich bekannte oder beliebte Aktie. Der Spitzenreiter iShares Nasdaq US Biotechnology UCITS ETF gewichtet Axsome Therapeutics mit 0,07% im ETF.
6 ETFs die in Axsome Therapeutics investieren
Dir gefallen die Informationen zu Axsome Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Zu BUX Zero
Dir gefallen die Informationen zu Axsome Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Zu Trade Republic
Dir gefallen die Informationen zu Axsome Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
Zur Comdirect
Dir gefallen die Informationen zu Axsome Therapeutics?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Zur ING Diba
34 News & Informationen zur Axsome Therapeutics Aktie
Axsome Therapeutics Provides Update on the New Drug Application for AXS-05 for the Treatment of Major Depressive Disorder
NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the…
Axsome Therapeutics Provides Update On The New Drug Application For AXS-05 For The Treatment Of Major Depressive Disorder
NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc. (NYSE: BIO) Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) Gilead Sciences, Inc. (NASDAQ: GILD) GlaxoSmithKline plc (NYSE: GSK) Johnson & Johnson (NYSE: JNJ) Laboratory Corporation of America Holdings (NYSE: LH) Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) NanoVibronix, Inc. (NASDAQ: NAOV) (announced intention to enter over-
3 Beaten Down Stocks that Could be Ready to Bounce
Photo credit sergeitokmakov @ Pixabay
Trading against the trend can be a very difficult way to generate returns in the market, yet there usually comes a …
Fairmount Funds Management LLC Buys Instil Bio Inc, Zogenix Inc, Insmed Inc, Sells Mirati Therapeutics Inc, Seres Therapeutics Inc, Trillium Therapeutics Inc
GuruFocus Article or News written by insider and the topic is about:
The Week Ahead In Biotech (Aug. 15-21): Fate Therapeutics Data Readout, RenovoRx IPO In Focus Amid Tapering Earnings News Flow
Biopharma stocks retreated in the week ending Aug. 13, defying the optimism that was found in the broader market. Earnings continued to domin…
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Au…
Scott Scott Attorneys At Law LLP Announces Investigation Into Axsome Therapeutics Inc. (AXSM)
Scott+Scott Attorneys at Law LLP (“Scott+Scott”), an international shareholder and consumer rights litigation firm, is investigating whether Axsome
Axsome Shares Fall Again Amid Downgrades on AXS-05 Worries
By Colin Kellaher
On the heels of Monday's nearly 50% drop, shares of Axsome Therapeutics Inc. fell further on Tuesday amid doubts the Food and Drug Administration will approve the company's… | August 10, 2021
Axsome Shares Fall Again Amid Downgrades on AXS-05 Worries
By Colin Kellaher
On the heels of Monday's nearly 50% drop, shares of Axsome Therapeutics Inc. fell further on Tuesday amid doubts the Food and Drug Administration will approve the company's… | August 10, 2021
Axsome Therapeutics Inc. Stock Quote (U.S.: Nasdaq)
AXSM | Complete Axsome Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
AXSM INVESTOR ALERT: Rosen Law Firm Encourages Axsome Therapeutics, Inc. Investors with Losses to Inquire About Class Action Investigation – AXSM
WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Axsome Therapeutics, Inc. resulting from allegations… | August 9, 2021
Mid-Afternoon Market Update: Aterian Falls After Q2 Results; Select Interior Concepts Shares Spike Higher
Toward the end of trading Monday, the Dow traded down 0.17% to 35,150.02 while the NASDAQ rose 0.26% to 14,874.23. The S&P also rose, gaining 0.01% to …
Axsome Therapeutics, Inc. (AXSM) CEO Herriot Tabuteau on Q2 2021 Results – Earnings Call Transcript
Call Start: 08:00 Call End: 08:56 Axsome Therapeutics, Inc.
Mid-Morning Market Update: Markets Mixed; DISH Network Profit Beats Estimates
Following the market opening Monday, the Dow traded down 0.19% to 35,141.90 while the NASDAQ rose 0.10% to 14,850.40. The S&P also fell, dropping 0.07% …
Axsome Therapeutics EPS beats by $0.07 (NASDAQ:AXSM)
Axsome Therapeutics (AXSM): Q2 GAAP EPS of -$0.86 beats by $0.07.Guidance: Axsome believes that its cash at June 30, 2021, along with the remaining committed capital from the $225…
Axsome Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Update
Company to host conference call today at 8:00 AM Eastern NEW YORK, Aug. 09, 2021 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a…
Axsome Therapeutics (AXSM) Sees Hammer Chart Pattern: Time to Buy?
Stocks Analysis by Zacks Investment Research covering: Axsome Therapeutics Inc. Read Zacks Investment Research's latest article on Investing.com
Earnings Scheduled For August 9, 2021
Companies Reporting Before The Bell
• Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $1.57 per share on revenue of …
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnin…
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 33 companies hit new 52-week lows.
Areas of Significance: The largest company in terms of market cap to set a new 52-week …
Is There Any Hope Left for Axsome Therapeutics?
After a fantastic run-up, investors are now losing faith in this emerging biotech's stock.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axsome Therapeutics, Inc. – AXSM
NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of Axsome Therapeutics, Inc. (“Axsome” or the…
Were Hedge Funds Right About Dumping Axsome Therapeutics, Inc. (AXSM)?
In this article we will analyze whether Axsome Therapeutics, Inc. (NASDAQ:AXSM) is a good investment right now by following the lead of some of the best…
Where Do Hedge Funds Stand On Quanterix Corporation (QTRX)?
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900…
Hedge Funds Are Coming Back To Arbor Realty Trust, Inc. (ABR)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data….
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axsome Therapeutics, Inc. – AXSM
NEW YORK, July 18, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Axsome Therapeutics, Inc. ('Axsome' or the…
Axsome Therapeutics To Report Second Quarter 2021 Financial Results On August 9, 2021
Axsome to host conference call and webcast on Monday, August 9, 2021 at 8:00 AM Eastern Time
NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) — Axsome Therapeutics,
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axsome Therapeutics, Inc. – AXSM
NEW YORK, July 14, 2021 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Axsome Therapeutics, Inc. ('Axsome' or the…
Why Shares of Axsome Therapeutics Are Falling Today
The FDA took back a beneficial designation but management isn't changing its plans.
Buy This Stock Before Everyone Else Does
This biotech has significant upside left.
Ditch Dogecoin: These 3 Stocks Could Double Your Money
The path to a twofold or greater return is straightforward for each of these stocks.
What’s Next For Axsome Therapeutics Stock After A 13% Rise In A Month?
The stock price of Axsome Therapeutics, a biopharmaceutical company focused on developing novel therapies for central nervous system conditions, has seen a 13% rise over the last twenty-one trading sessions. In a recent development, the company announced that it plans to submit a new drug…
Are Biotech Penny Stocks Worth It?
Biotech penny stocks can be an interesting addition to your investment portfolio and many investors are bringing in massive gains.